These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26941190)

  • 1. Enhancement of antitumor activity of the oxazaphosphorine cytostatic SUM-IAP by N-methylformamide.
    Voelcker G
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1183-9. PubMed ID: 26941190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostimulating and cancer-reductive experimental therapy with the oxazaphosphorine cytostatic SUM-IAP.
    Voelcker G
    Anticancer Drugs; 2018 Jun; 29(5):411-415. PubMed ID: 29465464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the alkylating function of aldo-Ifosfamide on the anti-tumor activity.
    Voelcker G
    Anticancer Drugs; 2018 Jan; 29(1):75-79. PubMed ID: 29219879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased antitumour activity of mesyl-I-aldophosphamide-perhydrothiazine, in vivo but not in vitro, compared to I-aldophosphamide-perhydrothiazine.
    Voelcker G; Pfeiffer B; Schnee A; Hohorst H
    J Cancer Res Clin Oncol; 2000 Feb; 126(2):74-8. PubMed ID: 10664245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
    Iwakawa M; Tofilon PJ; Arundel C; Milas L
    Cancer Res; 1989 Apr; 49(7):1640-3. PubMed ID: 2924311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-methylformamide-mediated enhancement of in vitro tumor cell chemosensitivity.
    Tofilon PJ; Vines CM; Milas L
    Cancer Chemother Pharmacol; 1986; 17(3):269-73. PubMed ID: 3742713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of unithiol on the antineoplastic and antimetastatic activity of N-methylformamide].
    Proskuriakov SIa; Fedorovskaia EO; Riabchenko NI; Poverennyĭ AM
    Vopr Med Khim; 1993; 39(3):32-4. PubMed ID: 8333188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of an injection of N-methylformamide into mice on the cell cycle and cell morphology of ascitic hepatoma 22A].
    Proskuriakov SIa; Guliaev VA; Smoryzanova OA; Nikolaeva TG; Dobrynin IaV; Riabchenko NI
    Tsitologiia; 1996; 38(2):129-34. PubMed ID: 8754129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of diethyldithiocarbamate on the hepatotoxic action and antitumor activity of N-methylformamide in mice.
    Masuda Y; Nakayama N; Yasoshima M
    Jpn J Pharmacol; 1986 Apr; 40(4):541-50. PubMed ID: 3016389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of sodium ascorbate, menadione sodium bisulfite or pyridoxal hydrochloride on the toxic and antineoplastic action of N-methylformamide in P 388 leukemia or M 5076 sarcoma in mice.
    Osswald H; Herrmann R; Youssef M
    Toxicology; 1987 Feb; 43(2):183-91. PubMed ID: 3810660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line.
    Cordeiro RF; Savarese TM
    Cancer Res; 1986 Mar; 46(3):1297-305. PubMed ID: 3943098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems.
    Iwakawa M; Tofilon PJ; Hunter N; Stephens LC; Milas L
    Clin Exp Metastasis; 1987; 5(4):289-300. PubMed ID: 3665221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methylformamide as a potential therapeutic approach in colon cancer.
    Del Bufalo D; Bucci B; D'Agnano I; Zupi G
    Dis Colon Rectum; 1994 Feb; 37(2 Suppl):S133-7. PubMed ID: 8313785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methylformamide affects spontaneous metastases of 3LL lines and increases natural killer activity of tumor-bearing mice.
    Greco C; Del Bufalo D; Giannarelli D; Marangolo M; Fuggetta MP; Bonmassar E; Zupi G
    Clin Exp Metastasis; 1990; 8(2):153-63. PubMed ID: 2317955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced X ray sensitivity of human colon tumor cells by combination of N-methylformamide with chemotherapeutic agents.
    Leith JT; Lee ES; Leite DV; Glicksman AS
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1423-7. PubMed ID: 2428792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD; O'Dwyer PJ; Trader MW
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of N-methylformamide on artificial and spontaneous metastases from a murine hepatocarcinoma.
    Tofilon PJ; Vines CM; Milas L
    Br J Cancer; 1987 Mar; 55(3):239-43. PubMed ID: 3567058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
    Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
    Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiazolidinyl- and perhydrothiazinylphosphamidesters: toxicity and preliminary antitumour evaluation.
    Voelcker G; Bielicki L; Hohorst HJ
    J Cancer Res Clin Oncol; 1997; 123(11-12):623-31. PubMed ID: 9620221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051).
    Cooksey PG; Gate EN; Gescher A; Hickman JA; Langdon SP; Stevens MF
    Biochem Pharmacol; 1983 Oct; 32(20):3037-43. PubMed ID: 6639672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.